123 related articles for article (PubMed ID: 9384711)
1. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
[TBL] [Abstract][Full Text] [Related]
2. Serum cytokine levels in patients undergoing bone marrow transplantation.
Chasty RC; Lamb WR; Gallati H; Roberts TE; Brenchley PE; Yin JA
Bone Marrow Transplant; 1993 Oct; 12(4):331-6. PubMed ID: 8275032
[TBL] [Abstract][Full Text] [Related]
3. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
4. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
Zhou J; Zhao Q; Yao H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
[TBL] [Abstract][Full Text] [Related]
5. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
6. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
Toren A; Barak V; Novick D; Nagler A
Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
[TBL] [Abstract][Full Text] [Related]
9. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
Tur-Kaspa I; Maor Y; Weissenberg R; Madgar I; Aderka D; Dor J; Mashiach S; Wallach D
J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
[TBL] [Abstract][Full Text] [Related]
10. Levels of soluble low affinity IL2 receptors (s-IL2 R) and TNF in the serum after BMT.
Alessandrino EP; Bernasconi P; Colombo A; Boni M; Bonfichi M; Caldera D; Bernasconi C
Bone Marrow Transplant; 1991; 7 Suppl 2():51. PubMed ID: 1878716
[No Abstract] [Full Text] [Related]
11. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
12. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
[TBL] [Abstract][Full Text] [Related]
13. High levels of serum interleukin-10 and tumor necrosis factor-alpha are associated with fatality in fulminant hepatitis.
Nagaki M; Iwai H; Naiki T; Ohnishi H; Muto Y; Moriwaki H
J Infect Dis; 2000 Oct; 182(4):1103-8. PubMed ID: 10979906
[TBL] [Abstract][Full Text] [Related]
14. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
15. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
[TBL] [Abstract][Full Text] [Related]
16. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
[TBL] [Abstract][Full Text] [Related]
17. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
[TBL] [Abstract][Full Text] [Related]
18. Delayed elevation of soluble tumor necrosis factor receptors p75 and p55 in cerebrospinal fluid and plasma after traumatic brain injury.
Maier B; Lehnert M; Laurer HL; Mautes AE; Steudel WI; Marzi I
Shock; 2006 Aug; 26(2):122-7. PubMed ID: 16878018
[TBL] [Abstract][Full Text] [Related]
19. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
Modzelewski B
Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
[TBL] [Abstract][Full Text] [Related]
20. Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3.
Bemelman FJ; Jansen J; van der Poll T; van Deventer SJ; ten Berge RJ
Nephrol Dial Transplant; 1994; 9(12):1786-90. PubMed ID: 7708265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
